These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32931060)
41. Cross-sectional survey of patients' need for information and support with medicines after discharge from hospital. Mackridge AJ; Rodgers R; Lee D; Morecroft CW; Krska J Int J Pharm Pract; 2018 Oct; 26(5):433-441. PubMed ID: 29152842 [TBL] [Abstract][Full Text] [Related]
42. [Safe Use of Recent New Drugs-Current Status and Challenges]. Ohashi Y Yakugaku Zasshi; 2018; 138(2):177-183. PubMed ID: 29386431 [TBL] [Abstract][Full Text] [Related]
43. An assessment of pregnant women's knowledge and use of the Internet for medication safety information and purchase. Sinclair M; Lagan BM; Dolk H; McCullough JEM J Adv Nurs; 2018 Jan; 74(1):137-147. PubMed ID: 28880394 [TBL] [Abstract][Full Text] [Related]
44. Hospital pharmacists understanding of available health literacy assessment tools and their perceived barriers for incorporation in patient education - a survey study. Chan S; Spina SP; Zuk DM; Dahri K BMC Health Serv Res; 2020 May; 20(1):401. PubMed ID: 32393241 [TBL] [Abstract][Full Text] [Related]
45. Experiences of and attitudes towards receiving information about non-steroidal anti-inflammatory drugs: a cross-sectional survey of patients in Thailand. Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J Expert Opin Drug Saf; 2016; 15(4):417-26. PubMed ID: 26742855 [TBL] [Abstract][Full Text] [Related]
46. Report of a mail survey of women with bladder control disorders. Newman DK Urol Nurs; 2004 Dec; 24(6):499-507. PubMed ID: 15658736 [TBL] [Abstract][Full Text] [Related]
47. Adverse drug reactions' reporting in a Mexican hospital. Valdez-Ramírez LA; Serrano-Medina A; Cornejo-Bravo JM Int J Pharm Pract; 2020 Dec; 28(6):660-662. PubMed ID: 32476179 [TBL] [Abstract][Full Text] [Related]
48. Quantitative study evaluating perception of general public towards role of pharmacist in health care system of Pakistan. Jin X; Azhar S; Murtaza G; Xue F; Mumtaz A; Niu H; Taha A; Zhang Y Acta Pol Pharm; 2014; 71(5):869-75. PubMed ID: 25362816 [TBL] [Abstract][Full Text] [Related]
49. Issues with prescribed medications in Aboriginal communities: Aboriginal health workers' perspectives. Hamrosi K; Taylor SJ; Aslani P Rural Remote Health; 2006; 6(2):557. PubMed ID: 16683907 [TBL] [Abstract][Full Text] [Related]
50. Risk Communication and the Pharmaceutical Industry: what is the reality? Edwards B; Chakraborty S Drug Saf; 2012 Nov; 35(11):1027-40. PubMed ID: 23061779 [TBL] [Abstract][Full Text] [Related]
51. Recognizing and Addressing Limited PHarmaceutical literacy: Development of the RALPH interview guide. Vervloet M; van Dijk L; Rademakers JJDJM; Bouvy ML; De Smet PAGM; Philbert D; Koster ES Res Social Adm Pharm; 2018 Sep; 14(9):805-811. PubMed ID: 29724680 [TBL] [Abstract][Full Text] [Related]
52. Med Wise: A theory-based program to improve older adults' communication with pharmacists about their medicines. Martin BA; Chewning BA; Margolis AR; Wilson DA; Renken J Res Social Adm Pharm; 2016; 12(4):569-77. PubMed ID: 26508269 [TBL] [Abstract][Full Text] [Related]
53. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries. Svensberg K; Sporrong SK; Björnsdottir I Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364 [TBL] [Abstract][Full Text] [Related]
54. Perceptions of pharmacists' role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care. Bastianelli KMS; Nelson L; Palombi L Curr Pharm Teach Learn; 2017; 9(2):195-200. PubMed ID: 29233403 [TBL] [Abstract][Full Text] [Related]
55. Demonstrating the value of community pharmacists in New Zealand educating a targeted group of people to temporarily discontinue medicines when they are unwell to reduce the risk of acute kidney injury. Vicary D; Hutchison C; Aspden T Int J Pharm Pract; 2020 Dec; 28(6):569-578. PubMed ID: 32945014 [TBL] [Abstract][Full Text] [Related]
56. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia. Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612 [No Abstract] [Full Text] [Related]
57. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon. Hajj A; Hallit S; Ramia E; Salameh P; Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813 [TBL] [Abstract][Full Text] [Related]
58. Health professionals: how do they assess new medicines? Cheng R; Cook K; Dowman S; Lawn R; Leary J; Quinn T; Schroder K; Smith N; Tordoff J Pharm World Sci; 2005 Jun; 27(3):236-42. PubMed ID: 16096894 [TBL] [Abstract][Full Text] [Related]
59. Public perceptions of the pharmaceutical industry and drug safety: implications for the pharmacovigilance professional and the culture of safety. Olsen AK; Whalen MD Drug Saf; 2009; 32(10):805-10. PubMed ID: 19722724 [TBL] [Abstract][Full Text] [Related]
60. Promoting health communication between the community-dwelling well-elderly and pharmacists: the Ask Me 3 program. Miller MJ; Abrams MA; McClintock B; Cantrell MA; Dossett CD; McCleeary EM; McGee MJ; O'Keefe KJ; Sager ER J Am Pharm Assoc (2003); 2008; 48(6):784-92. PubMed ID: 19019809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]